Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report.

World journal of gastroenterology - 14 Feb 2007

Suzuki Yuka, Yotsuyanagi Hiroshi, Okuse Chiaki, Nagase Yoshihiko, Takahashi Hideaki, Moriya Kyoji, Suzuki Michihiro, Koike Kazuhiko, Iino Shiro, Itoh Fumio

Abstract excerpt

We present a case of fetal liver failure caused by the activation of lamivudine-resistant hepatitis B virus (HBV) nine months after lamivudine treatment. A 57-year old man visited our hospital for the treatment of decompensated chronic hepatitis B. Lamivudine was started in December 2001. Subsequ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Fatal Outcome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Products, pol

Share to Hepatitis B

Share to Hepatitis B virus

Share to Lamivudine

Share to Liver Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 17352033
DOI: 10.3748/wjg.v13.i6.964
PMCID: PMC4065939

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17352033-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report.PMID 17352033Read ↗

Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant.Semantic proximity Read ↗

High rates of progressive hepatic functional deterioration whether lamivudine therapy is continued or discontinued after emergence of a lamivudine-resistant mutant: a prospective randomized controlled study.Semantic proximity Read ↗

Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis.Semantic proximity Read ↗

Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B.Semantic proximity Read ↗

Tenofovir rescue therapy in pregnant females with chronic hepatitis B.Semantic proximity Read ↗

Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy.Semantic proximity Read ↗

Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.Semantic proximity Read ↗

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.Semantic proximity Read ↗

Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.Semantic proximity Read ↗

Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.Semantic proximity Read ↗

Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient.Semantic proximity Read ↗

Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.